Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of efficacy and safety indicators of two iron chelators in patients with iron overload
2009-017799-26Phase 3Completed
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of deferasirox and deferoxamine in iron overload (2 arms), sponsored by Instituto Aragonés de Ciencias de la Salud. Primary endpoint: Reduction in serum ferritin concentration. Started Mar 2010; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
iron overload
Beyond the preview
Go deeper on 2009-017799-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017799-26.